1-4 of 4
Tomas Skacel, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study

Saad Z. Usmani, MD, Vania T. M. Hungria, MD PhD, Xavier Leleu, MD PhD, Hans C. Lee, MD, Faith E. Davies, MD, Caitlin L. Costello, MD, Robert M Rifkin, MD, Katja Weisel, MD, Ajai Chari, MD, Noemi Puig, MD PhD, Mario Boccadoro, MD, Gordon Cook, Jesus G. Berdeja, MD, Jeffrey A Zonder, MD, Michael A. Thompson, MD PhD FASCO, Rafat Abonour, MD, Jorge Vela-Ojeda, MD PhD, Roman Hajek, MD PhD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Jim Omel, MD, Brittany Demers, BS, BA, Dorothy Romanus, RPh, PhD, Kaili Ren, PhD, Tomas Skacel, MD PhD, Dawn Marie Stull, Pharm.D., BCOP, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3289.
https://doi.org/10.1182/blood-2018-99-112846
Published: 2018
Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Weijun Fu, MD PhD, Jin Lu, Jie Jin, MD PhD, Yan Xu, MD, Depei Wu, Dao-bin Zhou, MD, Xiaoyan Ke, Xin Du, MD PhD, Xiequn Chen, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kihyun Kim, MD PhD, Junmin Li, MD PhD, Jae Hoon Lee, MD PhD, Jing Liu, PhD, Yeow Tee Goh, MBBS, MD, Kwang-Wei Wu, MD, Hui Wang, MD, Guohui Liu, PhD, Tomas Skacel, MD PhD, Hui Wan, MD PhD, Deborah Berg, RN, MSN
Journal: Blood
Blood (2018) 132 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2018-99-116844
Published: 2018
Journal Articles

Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) - Effectiveness in Routine Clinical Practice Is Similar to the Efficacy in the Phase 3 Tourmaline-MM1 Trial: A Pooled Analysis from the Insight MM Observational Study and the Czech Registry of Monoclonal Gammopathies (RMG)

Roman Hajek, MD PhD, Evangelos Terpos, MD PhD, Hans C. Lee, MD, Ajai Chari, MD, Caitlin L. Costello, MD, Noemi Puig, MD PhD, Xavier Leleu, MD PhD, Jesus G. Berdeja, MD, Faith E. Davies, MD, Katja Weisel, MD, Saad Z. Usmani, MD, Vania T. M. Hungria, MD PhD, Mario Boccadoro, MD, Robert M Rifkin, MD, Jeffrey A Zonder, MD, Gordon Cook, Lucie Brožová, MSc, Magda Bařinová, MSc, Kaili Ren, PhD, Roxanne Cacioppo, Tomas Skacel, MD PhD, Dawn Marie Stull, Pharm.D., BCOP, Vladimir Maisnar, MD TMD, MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 1971.
https://doi.org/10.1182/blood-2018-99-113441
Published: 2018
Journal Articles

Maintenance Therapy with the Oral Proteasome Inhibitor (PI) Ixazomib Significantly Prolongs Progression-Free Survival (PFS) Following Autologous Stem Cell Transplantation (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 3 Tourmaline-MM3 Trial

Meletios A Dimopoulos, MD, Francesca Gay, MDPhD, Fredrik H. Schjesvold, MDPhD, Meral Beksac, MD, Roman Hajek, Katja Weisel, MD, Hartmut Goldschmidt, MD, Vladimir Maisnar, MD, Philippe Moreau, Chang-Ki Min, MD PhD, Agnieszka Pluta, MD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Martin Kaiser, MD, Sonja Zweegman, MDPhD, Maria-Victoria Mateos, MD PhD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Shinsuke Iida, MDPhD, Gareth Morgan, MD, Zhaoyang Teng, PhD, Kaveri Suryanarayan, MD, Tomas Skacel, MD PhD, Ajeeta B Dash, PhD, Richard Labotka, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 301.
https://doi.org/10.1182/blood-2018-99-112079
Published: 2018